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Abstract
We have used electron and photon beams from the 50
MV electron microtron at UM Hospital together with a
large-bore 3.5T superconducting solenoid to
demonstrate the magnetic confinement of HE electron
and photon beam-dose profiles for typical radiotherapy
beams. The HE electron beams in particular exhibit a
large reduction in penumbra when entering a tissue-
equivalent phantom and, in addition, confinement of
the secondary electrons produced by the primary beam.
Likewise photon beams show a similar confinement of
the dose from secondary electrons. While the results
resemble features predicted from Monte Carlo
calculations, there are a number of anomalous details in
the actual experimental data which serve to illustrate
the problems associated with practical clinical
implementations. However the data suggest that in
certain cases HE electrons may provide a cost-effective
alternate to proton or HI radiotherapy beams and, also,
improve the dose profile for HE photon beams.
1 INTRODUCTION
Monte Carlo simulations [1-5] and more recently,
experiments [6] have shown that application of a strong
magnetic field can provide a substantial improvement
and control of the dose profile of clinical electron and
photon radiotherapy beams. Other calculations also
indicate some improvement in the dose profile for
proton-therapy beams but to a much lesser extent than
predicted for electron beams. The effect with proton
beams, as well as photon beams, is in the confinement
of the secondary electrons and recoil ions and not
confinement or focusing of the primary beam itself.
This would also presumably apply to neutron-beam
therapy, or boron-neutron capture therapy (BNCT)
where the secondary particles would also be confined.
As noted below, tissue-air interfaces (e.g. lung)
can cause problems in conventional radiotherapy due to
beam spreading at the air-tissue interface regions. In
particular, however, we wish to show that the magnetic
confinement and focusing of primary high-energy
electron beams could make these beams more useful in
radiotherapy and, perhaps, provide a viable alternative
to proton- or heavy-ion beam therapy in some
treatments. A number of technical challenges remain,
but much of the technology developed for construction
of compact superconducting cyclotron magnets,
including gantry-mounted cyclotrons [7] can likely be
utilized to develop clinical devices.
2 HIGH-ENERGY ELECTRON-BEAM
FOCUSING AND DOSE CONFINEMENT
In order to examine some of the technical issues
involving the utilization of magnetic focusing and dose
confinement in a clinical setting a series of experiments
were performed at the Radiation Oncology Department
at the University of Michigan Hospital. The Scantronix
MM50 50 MV electron racetrack microtron coupled to
an isocentric G50 treatment gantry which includes a
photon converter and collimator head was used to
produce HE electron and photon beams [8],
A large warm-bore (20 cm) by 40 cm long air-core
super-conducting solenoid [9] was installed 2.5 m from
the gantry vacuum window with the primary electron
beams passing through a helium gas-filled bag to
reduce beam scatter (Fig. 1). Beam profiles without a
phantom and dose profiles in a polystyrene phantom
were recorded on x-ray films suitably located in the
phantom. These were then scanned and digitized.
Complete details can be found in Ref [6],
The dose profiles are deduced from the digitized-film
optical-density information. Such data are shown in
Figs. 2 and 3 for collimated 50 MV and 20 MV
electron beams in the phantom. Dose profiles for the
20 MeV electron beam (B = 0 and 3T) passing through
a 5 cm diameter collimator located at the entrance of
the phantom are shown in Fig 3. The data shown in
Fig. 3 include the film-density to dose conversion but
otherwise show the same features observed with the 50
MeV beam (Fig. 2). Optical-density profiles (closely
related to dose) taken along the central beam axis and
perpendicular to the beam axis at selected points for the
50 MeV beam are shown in Fig. 4
As expected, the 3T field results in a substantial
focusing of the primary electron beam and, in addition
confines the resulting dose profile. In particular the
large penumbra typically associated with electron
beams, which limits their use in radiation therapy, is
significantly reduced. Likewise one expects the tissue-
air interface problem to also be minimized [10],
especially if Tesla-level fields can be applied.
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As noted in [6] the experimental data show several
features different than predicted by Monte Carlo (MC)
calculations due to differences in the assumed field
profiles and, also, due to some important features such
as primary-beam focusing not included precisely in the
MC calculations. In particular the Bragg-like dose
profile predicted [3] is not seen to the extent predicted.
Nonetheless, the dose profiles for the confined high-
energy electron beams exhibit features similar to those
for proton- therapy beams in tissue especially when the
latter are modulated to treat cm-size tumors. This
suggests that focused and confined electron beams
could provide a relatively low-cost alternative to proton
therapy for certain treatments.
3 TECHNICAL ISSUES
Obviously there are a number of technical issues
which must be addressed for the clinical application of
magnetic confinement of radiotherapy beams. In our
experiments the steel yoke of the gantry (Fig. 1) caused
a perturbation of the solenoid field [6] so obviously a
non-magnetic gantry would be preferable. In addition,
the magnetic field .affected the beam optics in the
gantry resulting in a non-uniform treatment beam. A
large-bore magnet would be needed for patient
treatment depending on the area being treated and the
treatment plan. Large-bore NbTi (up to 9T) and,
recently, NbSn (up to 14T) are available although NbSn
magnets remain expensive.
Alternately, large split-coil magnets perhaps with
cryocoolers mounted together with the beam delivery
system on a suitable gantry also appear feasible. It
should be noted that the axial fringe field of the magnet
actually adds focusing for an on-axis beam, e.g. a beam
from a gantry-mounted linac if it's on the magnet axis.
4 FUTURE WORK
One issue that we hope to study is the effect of
magnetic confinement on the radiobiological effect
(RBE) of various radiotherapy beams. This is in
addition to the dose confinement as the latter as
presently measured (x-ray film) doesn't include any
RBE enhancement e.g. from the confinement of
secondary delta rays.
Likewise, in conjunction with imaging studies using
positron-emission tomography (PET), it has been
shown [11] that a magnetic field can be used to confine
the P+ emission from the PET isotope being imaged
and hence improve the PET spatial resolution. This
might also have applications in the PET imaging of P+
emitters produced in proton-beam[12] or heavy-ion
beam radiotherapy. Related to this is the possibility of
using magnetic confinement in selected brachytherapy
treatments where, again, one might be dealing with
high-energy hence long-range charged, radioactive-
decay particles (fT, P+, or cc's).
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Figure 1: Experimental arrangement showing the
superconducting solenoid with phantom (left) and
helium bag at exit G50 microtron radiotherapy gantry
(right).
Figure 2: Film-density scans of a 5 cm diameter
collimated 50 MeV electron beam in a polystyrene
phantom without (left) and with (right) a 3T applied
field.
Figure 4: Optical density scans, proportional to dose,
taken along the beam axis (top) and perpendicular to
the beam axis (bottom) near the maximum in the
magnetically-confined 50 MeV electron beam profile
(Fig. 2)
Figure 3: Isodose profiles for a 5 cm diameter 20 MV
electron beam in a polystyrene phantom without (left)
and with (right) an applied 3T field along the incident
beam direction (vertical axis).
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